Oxus Medical, Inc was founded to bring to market a novel device for implanting left ventricle pacemaker leads during Cardiac Resynchronization Therapy (CRT). This device, a steerable oximetric catheter with a proximal end and a distal end, was originally created at the Health Sciences Center of Tulane University. The device has a blood oxygen sensor connected and disposed to sense the percentage of oxygen saturation of blood at the distal end as itâs placed in the right atrium of the heart. The catheter has a steering mechanism selectively operable by the operator to deflect the distal tip towards regions of relatively low percent oxygen saturation. By sensing the oxygen concentration at the distal tip of the catheter and steering it towards a region of lower oxygen concentration, the location of the coronary sinus can be determined. Once the location of orifice of the coronary sinus is found, it can be cannulized to allow for the placement of a ventricular pacing lead. Oxus medical owns an exclusive license to develop the steerable oxygen sensor catheter and assist in the eventual commercialization of this product. Since that time, the company has created several working prototypes of the device, and has performed three animal studies (canines)